Skip to main content
Top
Published in: Clinical & Experimental Metastasis 1/2024

Open Access 04-01-2024 | Metastasis | Research

Acetone compression improves lymph node yield and metastasis detection in colorectal cancer

Authors: Christina Schnoz, Katrin Schmid, Guacimara Ortega Sanchez, Sabina Schacher-Kaufmann, Michel Adamina, Georgios Peros, Dieter Erdin, Peter Karl Bode

Published in: Clinical & Experimental Metastasis | Issue 1/2024

Login to get access

Abstract

Lymph node status is one of the most important prognostic factors in colorectal cancer, and accurate pathological nodal staging and detection of lymph node metastases is crucial for determination of post-operative management. Current guidelines, including the TNM staging system and European Society for Medical Oncology (ESMO) guidelines, recommend examination of at least 12 lymph nodes. However, identification of an adequate number of lymph nodes can be challenging, especially in the setting of neoadjuvant treatment, which may reduce nodal size. In this study, we investigated 384 colorectal cancer resections that were processed at our department of pathology between January 2012 and December 2022, in which the number of detected lymph nodes was less than 12 subsequent to conventional preparation of mesocolic fat tissue. By means of acetone compression, lymph node harvest increased significantly (p < 0.0001), and the intended number of ≥ 12 lymph nodes was achieved in 98% of resection specimens. The number of nodal positive cases increased significantly from n = 95 (24.7%) before versus n = 131 (34.1%) after acetone compression due to additionally identified lymph node metastases (p < 0.001). In 36 patients (9.4%) initially considered as nodal negative, acetone compression led to a staging adjustment to a nodal positive category and thereby drove a recommendation to offer post-operative therapy. In conclusion, acetone compression is a reliable and useful method implementable in routine surgical pathology for the retrieval of lymph nodes in colorectal cancer specimen, allowing for an adequate lymph node sampling and an increase in nodal staging reliability.
Literature
6.
go back to reference Brierley JD, Gospodarowicz MK, Wittekind C (eds) (2017) The TNM classification of malignant tumours. 8th edition. Oxford: Wiley Blackwell Brierley JD, Gospodarowicz MK, Wittekind C (eds) (2017) The TNM classification of malignant tumours. 8th edition. Oxford: Wiley Blackwell
8.
go back to reference Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM (2004) Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon Cancer: who benefits and by how much? J Clin Oncol 22(10):1797–1806. https://doi.org/10.1200/JCO.2004.09.059CrossRefPubMed Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM (2004) Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon Cancer: who benefits and by how much? J Clin Oncol 22(10):1797–1806. https://​doi.​org/​10.​1200/​JCO.​2004.​09.​059CrossRefPubMed
9.
go back to reference Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC (1998) For patients with dukes’ B (TNM stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer 83(4):666–672 PMID: 9708929CrossRefPubMed Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC (1998) For patients with dukes’ B (TNM stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer 83(4):666–672 PMID: 9708929CrossRefPubMed
13.
go back to reference Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, Hammond ME, Henson DE, Hutter RV, Nagle RB, Nielsen ML, Sargent DJ, Taylor CR, Welton M, Willett C (2000) Prognostic factors in Colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124(7):979–994. https://doi.org/10.5858/2000-124-0979-PFICCCrossRefPubMed Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, Hammond ME, Henson DE, Hutter RV, Nagle RB, Nielsen ML, Sargent DJ, Taylor CR, Welton M, Willett C (2000) Prognostic factors in Colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124(7):979–994. https://​doi.​org/​10.​5858/​2000-124-0979-PFICCCrossRefPubMed
15.
go back to reference Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann H, Wittekind C, Beissbarth T, Rödel C (2012) Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 30(16):1926–1933. https://doi.org/10.1200/JCO.2011.40.1836CrossRefPubMed Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann H, Wittekind C, Beissbarth T, Rödel C (2012) Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 30(16):1926–1933. https://​doi.​org/​10.​1200/​JCO.​2011.​40.​1836CrossRefPubMed
18.
go back to reference Collette L, Bosset JF, den Dulk M, Nguyen F, Mineur L, Maingon P, Radosevic-Jelic L, Piérart M, Calais G (2007) European Organisation for Research and Treatment of Cancer Radiation Oncology Group: patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol 25:4379–4386. https://doi.org/10.1200/JCO.2007.11.9685CrossRefPubMed Collette L, Bosset JF, den Dulk M, Nguyen F, Mineur L, Maingon P, Radosevic-Jelic L, Piérart M, Calais G (2007) European Organisation for Research and Treatment of Cancer Radiation Oncology Group: patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol 25:4379–4386. https://​doi.​org/​10.​1200/​JCO.​2007.​11.​9685CrossRefPubMed
25.
go back to reference Sprenger T, Rothe H, Becker H, Beissbarth T, Homayounfar K, Gauss K, Kitz J, Wolff H, Scheel AH, Ghadimi M, Rödel C, Conradi LC, Liersch T (2013) Lymph node metastases in rectal cancer after preoperative radiochemotherapy: impact of intramesorectal distribution and residual micrometastatic involvement. Am J Surg Pathol 37(8):1283–1289. https://doi.org/10.1097/PAS.0b013e3182886cedCrossRefPubMed Sprenger T, Rothe H, Becker H, Beissbarth T, Homayounfar K, Gauss K, Kitz J, Wolff H, Scheel AH, Ghadimi M, Rödel C, Conradi LC, Liersch T (2013) Lymph node metastases in rectal cancer after preoperative radiochemotherapy: impact of intramesorectal distribution and residual micrometastatic involvement. Am J Surg Pathol 37(8):1283–1289. https://​doi.​org/​10.​1097/​PAS.​0b013e3182886ced​CrossRefPubMed
26.
go back to reference Sprenger T, Rothe H, Conradi LC, Beissbarth T, Kauffels A et al (2016) Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup. Diseases of the Colon & Rectum 59(5):p 377–385. https://doi.org/10.1097/DCR.0000000000000570 Sprenger T, Rothe H, Conradi LC, Beissbarth T, Kauffels A et al (2016) Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup. Diseases of the Colon & Rectum 59(5):p 377–385. https://​doi.​org/​10.​1097/​DCR.​0000000000000570​
27.
go back to reference Basten O, Bandorski D, Bismarck C, Neumann K, Fisseler-Eckhoff A (2010) Acetonkompression. Schnelle, standardisierte Methode Zur Untersuchung Von Lymphknoten Im Gastrointestinaltrakt [Acetone compression. A fast, standardized method to investigate gastrointestinal lymph nodes]. Pathologe 31(3):218–224. https://doi.org/10.1007/s00292-009-1256-7CrossRefPubMed Basten O, Bandorski D, Bismarck C, Neumann K, Fisseler-Eckhoff A (2010) Acetonkompression. Schnelle, standardisierte Methode Zur Untersuchung Von Lymphknoten Im Gastrointestinaltrakt [Acetone compression. A fast, standardized method to investigate gastrointestinal lymph nodes]. Pathologe 31(3):218–224. https://​doi.​org/​10.​1007/​s00292-009-1256-7CrossRefPubMed
28.
go back to reference Gehoff A, Basten O, Sprenger T, Conradi LC, Bismarck C, Bandorski D, Merkelbach-Bruse S, Schneider-Stock R, Stoehr R, Wirtz RM, Kitz J, Müller A, Hartmann A, Becker H, Ghadimi BM, Liersch T, Rüschoff J (2012) Optimal lymph node harvest in rectal cancer (UICC stages II and III) after preoperative 5-FU-based radiochemotherapy. Acetone compression is a new and highly efficient method. Am J Surg Pathol 36(2):202–213. https://doi.org/10.1097/PAS.0b013e31823fa35bCrossRefPubMed Gehoff A, Basten O, Sprenger T, Conradi LC, Bismarck C, Bandorski D, Merkelbach-Bruse S, Schneider-Stock R, Stoehr R, Wirtz RM, Kitz J, Müller A, Hartmann A, Becker H, Ghadimi BM, Liersch T, Rüschoff J (2012) Optimal lymph node harvest in rectal cancer (UICC stages II and III) after preoperative 5-FU-based radiochemotherapy. Acetone compression is a new and highly efficient method. Am J Surg Pathol 36(2):202–213. https://​doi.​org/​10.​1097/​PAS.​0b013e31823fa35b​CrossRefPubMed
30.
go back to reference Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2017) The Eighth Edition AJCC Cancer staging Manual: continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin 67(2):93–99. https://doi.org/10.3322/caac.21388CrossRefPubMed Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2017) The Eighth Edition AJCC Cancer staging Manual: continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin 67(2):93–99. https://​doi.​org/​10.​3322/​caac.​21388CrossRefPubMed
43.
48.
go back to reference WHO (1970) Acetone: biological data. Toxicological evaluation of some solvents and certain other substances. Food and Agriculture Organization Nutrition Meetings Report Series 48A. United Nations, World Health Organization, Geneva, Switzerland, pp 86–90 WHO (1970) Acetone: biological data. Toxicological evaluation of some solvents and certain other substances. Food and Agriculture Organization Nutrition Meetings Report Series 48A. United Nations, World Health Organization, Geneva, Switzerland, pp 86–90
Metadata
Title
Acetone compression improves lymph node yield and metastasis detection in colorectal cancer
Authors
Christina Schnoz
Katrin Schmid
Guacimara Ortega Sanchez
Sabina Schacher-Kaufmann
Michel Adamina
Georgios Peros
Dieter Erdin
Peter Karl Bode
Publication date
04-01-2024
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 1/2024
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-023-10259-x

Other articles of this Issue 1/2024

Clinical & Experimental Metastasis 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine